ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Isotopes & Radiation
Members are devoted to applying nuclear science and engineering technologies involving isotopes, radiation applications, and associated equipment in scientific research, development, and industrial processes. Their interests lie primarily in education, industrial uses, biology, medicine, and health physics. Division committees include Analytical Applications of Isotopes and Radiation, Biology and Medicine, Radiation Applications, Radiation Sources and Detection, and Thermal Power Sources.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Feb 2025
Jul 2024
Latest Journal Issues
Nuclear Science and Engineering
March 2025
Nuclear Technology
Fusion Science and Technology
February 2025
Latest News
Colin Judge: Testing structural materials in Idaho’s newest hot cell facility
Idaho National Laboratory’s newest facility—the Sample Preparation Laboratory (SPL)—sits across the road from the Hot Fuel Examination Facility (HFEF), which started operating in 1975. SPL will host the first new hot cells at INL’s Materials and Fuels Complex (MFC) in 50 years, giving INL researchers and partners new flexibility to test the structural properties of irradiated materials fresh from the Advanced Test Reactor (ATR) or from a partner’s facility.
Materials meant to withstand extreme conditions in fission or fusion power plants must be tested under similar conditions and pushed past their breaking points so performance and limitations can be understood and improved. Once irradiated, materials samples can be cut down to size in SPL and packaged for testing in other facilities at INL or other national laboratories, commercial labs, or universities. But they can also be subjected to extreme thermal or corrosive conditions and mechanical testing right in SPL, explains Colin Judge, who, as INL’s division director for nuclear materials performance, oversees SPL and other facilities at the MFC.
SPL won’t go “hot” until January 2026, but Judge spoke with NN staff writer Susan Gallier about its capabilities as his team was moving instruments into the new facility.
William A. Neuman, James L. Jones
Nuclear Technology | Volume 92 | Number 1 | October 1990 | Pages 77-92
Technical Paper | Development of Nuclear Gas Cleaning and Filtering Techniques / Fission Reactor | doi.org/10.13182/NT90-A34488
Articles are hosted by Taylor and Francis Online.
A conceptual design of a passively safe reactor facility for boron neutron capture therapy is presented. The facility configuration and its neutronic, thermalhydraulic, and safety issues are addressed in order to demonstrate the deployability of reactor technology for routine patient treatments and advanced research and dosimetry. The reactor has a power level of <10 MW(thermal) and is based on low-enriched UZrH fuel. The reactor facility generates a clean epithermal neutron beam capable of treating deep-seated brain tumors (∼70 mm) in <10 min. The incident fast neutron and gamma-ray contaminants in the beam are 1.8 and 0.4 Gy, respectively, for a 20-Gy therapeutic dose to a deep-seated tumor. With an expected operation schedule of ∼2000 treatment periods per year, the reactor core lifetime is equal to the 30-yr facility lifetime and no refueling is necessary. Five beam ports are available for simultaneous patient treatments allowing between 2000 and 10000 treatments per year with expansion capabilities of at least threefold for 24 h/day operation. The cost per patient treatment is small, about $1000, making the therapy very affordable. The reactor system design includes several passive safety features that allow the reactor to respond in a safe and benign manner in the event of off-normal transients. The response for various instantaneous reactivity insertions is assessed. Results show the reactor can passively respond to a reactivity insertion of 2 $ such that the maximum temperature limits of the fuel are not exceeded.